| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.5 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |